Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2012Open Access

Histone deacetylase inhibition: an important mechanism in the treatment of lymphoma.

View Full Paper
Ask AI
Bookmark
Share

Authors

SGShan GuoQingdao UniversityYZYi Zhuo Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guo et al. (2012) studied this question.

synapsesocial.com/papers/6aa27598da8566d019e56752https://doi.org/10.3969/j.issn.2095-3941.2012.02.001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylation2000 · 1,101 citations
  2. 2Epigenetics and B-cell lymphoma2011 · 69 citations
  3. 3Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)2006 · 1,142 citations
  4. 4Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair2010 · 380 citations